China Health Industries Holdings Operating Income 2016-2024 | CHHE

China Health Industries Holdings operating income from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

China Health Industries Holdings Operating Income 2016-2024 | CHHE

China Health Industries Holdings operating income from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$170.6B
Vertex Pharmaceuticals (VRTX)$117.1B
Regeneron Pharmaceuticals (REGN)$111.8B
Bristol Myers Squibb (BMY)$109.9B
Gilead Sciences (GILD)$104.8B
CSL (CSLLY)$95.8B
GSK (GSK)$79.5B
Alnylam Pharmaceuticals (ALNY)$34.6B
Argenex SE (ARGX)$32.5B
BioNTech SE (BNTX)$28.5B
Biogen (BIIB)$26.9B
Moderna (MRNA)$23.5B
BeiGene (BGNE)$22.7B
Illumina (ILMN)$21.7B
Genmab (GMAB)$15.5B
BioMarin Pharmaceutical (BMRN)$12.9B
Incyte (INCY)$12.9B
Vaxcyte (PCVX)$12.4B
Exact Sciences (EXAS)$12.3B
Insmed (INSM)$12.3B
Bio-Techne Corp (TECH)$11.7B
Sarepta Therapeutics (SRPT)$11.3B
QIAGEN (QGEN)$9.9B
Bio-Rad Laboratories (BIO.B)$9.3B
Legend Biotech (LEGN)$8.7B
Roivant Sciences (ROIV)$8.3B
Ascendis Pharma (ASND)$8.2B
Repligen (RGEN)$7.8B
Revolution Medicines (RVMD)$7.7B
Halozyme Therapeutics (HALO)$7.7B